Otenabant
Otenabant (CP-945598) is a selective cannabinoid CB1 receptor antagonist researched for obesity treatment. It has been utilized in both in vitro binding assays and in vivo animal studies to investigate energy homeostasis and metabolic pathways.
Product Specifications
CAS Number
686344-29-6
Product Name Alternative
Cannabinoid Receptor, CannabinoidReceptor, CB1, CB, CP 945598, CP945598, CP-945598, inhibit, Otenabant, Inhibitor
Field of Research
Pharmacology & Drug Discovery
Purity
99.43% (May vary between batches)
Solubility
DMSO:10 mg/mL (19.59 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.96 mM)
Smiles
CCNC1 (CCN (CC1) c1ncnc2n (c (nc12) -c1ccccc1Cl) -c1ccc (Cl) cc1) C (N) =O
Molecular Formula
C25H25Cl2N7O
Molecular Weight
510.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C5072-58B-AP 100 µL
CIDE-3 (Cell death activator CIDE-3, Cell death-inducing DFFA-like effector protein C, Fat-specific protein FSP27 homolog, FLJ20871, Fsp27, FSP27) (AP) discontinued
Sign In for Pricing
View Details 